Evaluation of the Safety and Efficacy of HSK39004 Dry Powder Inhaler in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT07108699 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07108699
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-13
- Primary completion
- 2026-08-30
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.